Table 4.
Helkimo Index and Patient Global Impression of Change Scale.
| CG (n = 8) |
EG (n = 8) |
|||||
|---|---|---|---|---|---|---|
| T0 | T1 | T2 | T0 | T1 | T2 | |
| Helkimo Index, frequency, (%) | ||||||
| Absence (0 points) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Mild (1–4 points) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 4 (50%) | 3 (37.5%) |
| Moderate (5–9 points) | 6 (75%) | 5 (62.5%) | 5 (62.5%) | 4 (50%) | 4 (50% | 5 (62.5%) |
| Severe (10–25 points) | 2 (25%) | 3 (37.5%) | 3 (37.5%) | 4 (50%) | 0 (0%) | 0 (0%) |
| PGICS, frequency, (%) | ||||||
| 1 = “very much improved” | 0 (0%) | 2 (25%) | ||||
| 2 = “much improved” | 0 (0%) | 4 (50%) | ||||
| 3 = “minimally improved” | 2 (25%) | 0 (0%) | ||||
| 4 = “no change” | 2 (25%) | 1 (12.5%) | ||||
| 5 = “minimally worse” | 4 (50%) | 1 (12.5%) | ||||
| 6 = “much worse” | 0 (0%) | 0 (0%) | ||||
| 7 = “very much worse” | 0 (0%) | 0 (0%) | ||||
Abbreviations: CG = control group; EG = experimental group; T0 = baseline measurement; T1 = post-treatment measurement; T2 = 1-month follow-up measurement; and PGICS: Patient Global Impression of Change Scale.